Your shopping cart is currently empty

TUG-770 is a GPR40/FFA1 agonist with potential anti-inflammatory activity.TUG-770 can be used to study type 2 diabetes, dementia, and Alzheimer's disease.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $58 | - | In Stock | |
| 5 mg | $139 | - | In Stock | |
| 10 mg | $222 | 5 days | 5 days | |
| 25 mg | $429 | 7-10 days | 7-10 days | |
| 50 mg | $687 | 7-10 days | 7-10 days | |
| 100 mg | $987 | 7-10 days | 7-10 days | |
| 500 mg | $1,980 | 7-10 days | 7-10 days | |
| 1 mL x 10 mM (in DMSO) | $213 | 5 days | 5 days |
| Description | TUG-770 is a GPR40/FFA1 agonist with potential anti-inflammatory activity.TUG-770 can be used to study type 2 diabetes, dementia, and Alzheimer's disease. |
| Targets&IC50 | FFA1/GPR40 (human):6 nM (EC50) |
| In vitro | TUG-770 shows good stability towards human liver microsomes (HLM) and demonstrates good permeability in the Caco-2 cell assay[1]. |
| In vivo | In C57BL/6 male mice (5-6 weeks of age) fed a 60% fat diet D12492, TUG-770 (20 mg/kg; oral administration; daily; for 28 days) significantly improved glucose tolerance[1]. |
| Synonyms | TUG770, TUG 770 |
| Molecular Weight | 307.32 |
| Formula | C19H14FNO2 |
| Cas No. | 1402601-82-4 |
| Smiles | OC(=O)CCc1ccc(cc1F)C#Cc1ccccc1CC#N |
| Relative Density. | 1.28 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: Insoluble DMSO: 100 mg/mL (325.39 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (10.74 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.